• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模拟抗体依赖增强对寨卡病毒和登革病毒序贯感染及共感染疾病严重程度的影响。

Modelling the impact of antibody-dependent enhancement on disease severity of Zika virus and dengue virus sequential and co-infection.

作者信息

Tang Biao, Xiao Yanni, Sander Beate, Kulkarni Manisha A, Wu Jianhong

机构信息

Laboratory for Industrial and Applied Mathematics (LIAM), York University, Toronto, Canada.

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.

出版信息

R Soc Open Sci. 2020 Apr 15;7(4):191749. doi: 10.1098/rsos.191749. eCollection 2020 Apr.

DOI:10.1098/rsos.191749
PMID:32431874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7211844/
Abstract

Human infections with viruses of the genus , including dengue virus (DENV) and Zika virus (ZIKV), are of increasing global importance. Owing to antibody-dependent enhancement (ADE), secondary infection with one following primary infection with another can result in a significantly larger peak viral load with a much higher risk of severe disease. Although several mathematical models have been developed to quantify the virus dynamics in the primary and secondary infections of DENV, little progress has been made regarding secondary infection of DENV after a primary infection of ZIKV, or DENV-ZIKV co-infection. Here, we address this critical gap by developing compartmental models of virus dynamics. We first fitted the models to published data on dengue viral loads of the primary and secondary infections with the observation that the primary infection reaches its peak much more gradually than the secondary infection. We then quantitatively show that ADE is the key factor determining a sharp increase/decrease of viral load near the peak time in the secondary infection. In comparison, our simulations of DENV and ZIKV co-infection (simultaneous rather than sequential) show that ADE has very limited influence on the peak DENV viral load. This indicates pre-existing immunity to ZIKV is the determinant of a high level of ADE effect. Our numerical simulations show that (i) in the absence of ADE effect, a subsequent co-infection is beneficial to the second virus; and (ii) if ADE is feasible, then a subsequent co-infection can induce greater damage to the host with a higher peak viral load and a much earlier peak time for the second virus, and for the second peak for the first virus.

摘要

人类感染包括登革热病毒(DENV)和寨卡病毒(ZIKV)在内的该属病毒,在全球范围内的重要性日益增加。由于抗体依赖增强(ADE)作用,在初次感染一种病毒后再感染另一种病毒,可能会导致病毒载量峰值显著增大,且患重病的风险更高。尽管已经开发了几种数学模型来量化登革热病毒初次和二次感染中的病毒动态,但在寨卡病毒初次感染后登革热病毒的二次感染或登革热病毒与寨卡病毒共感染方面进展甚微。在此,我们通过开发病毒动态的房室模型来填补这一关键空白。我们首先将模型拟合到已发表的关于登革热病毒初次和二次感染病毒载量的数据,观察到初次感染达到峰值的过程比二次感染更为缓慢。然后我们定量表明,ADE是决定二次感染峰值时间附近病毒载量急剧增减的关键因素。相比之下,我们对登革热病毒和寨卡病毒共感染(同时而非相继感染)的模拟表明,ADE对登革热病毒载量峰值的影响非常有限。这表明对寨卡病毒的预先存在的免疫力是高水平ADE效应的决定因素。我们的数值模拟表明:(i)在没有ADE效应的情况下,随后的共感染对第二种病毒有益;(ii)如果ADE可行,那么随后的共感染会对宿主造成更大损害,第二种病毒的病毒载量峰值更高,且峰值时间更早,第一种病毒的第二个峰值也是如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/1b3659056b5b/rsos191749-g9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/a4251bc28a15/rsos191749-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/5d5a216e5222/rsos191749-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/199b215ce347/rsos191749-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/2749a3dbdc48/rsos191749-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/049566a3065e/rsos191749-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/2acc87684cf1/rsos191749-g7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/e72bc8b6ed65/rsos191749-g8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/1b3659056b5b/rsos191749-g9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/a4251bc28a15/rsos191749-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/5d5a216e5222/rsos191749-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/199b215ce347/rsos191749-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/2749a3dbdc48/rsos191749-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/049566a3065e/rsos191749-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/2acc87684cf1/rsos191749-g7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/e72bc8b6ed65/rsos191749-g8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2807/7211844/1b3659056b5b/rsos191749-g9.jpg

相似文献

1
Modelling the impact of antibody-dependent enhancement on disease severity of Zika virus and dengue virus sequential and co-infection.模拟抗体依赖增强对寨卡病毒和登革病毒序贯感染及共感染疾病严重程度的影响。
R Soc Open Sci. 2020 Apr 15;7(4):191749. doi: 10.1098/rsos.191749. eCollection 2020 Apr.
2
Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.抗体依赖性增强作用对登革热/寨卡病毒致病性的调节作用及寨卡病毒感染中预防增强作用的策略。
Front Immunol. 2018 Apr 23;9:597. doi: 10.3389/fimmu.2018.00597. eCollection 2018.
3
Viral Load and Cytokine Response Profile Does Not Support Antibody-Dependent Enhancement in Dengue-Primed Zika Virus-Infected Patients.病毒载量和细胞因子反应谱不支持登革热病毒感染的 Zika 病毒患者的抗体依赖性增强。
Clin Infect Dis. 2017 Oct 15;65(8):1260-1265. doi: 10.1093/cid/cix558.
4
A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection.1型登革病毒抗体依赖性增强在既往寨卡病毒感染后的1例死亡病例报告
BMC Infect Dis. 2021 Aug 4;21(1):749. doi: 10.1186/s12879-021-06482-0.
5
Prior dengue virus serotype 3 infection modulates subsequent plasmablast responses to Zika virus infection in rhesus macaques.先前的登革热病毒3型感染可调节恒河猴随后对寨卡病毒感染的浆母细胞反应。
mBio. 2024 Mar 13;15(3):e0316023. doi: 10.1128/mbio.03160-23. Epub 2024 Feb 13.
6
Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models.登革热和 Zika 病毒感染可被减毒活疫苗增强,但在小鼠模型中,重组 DSV4 候选疫苗不会增强登革热感染。
EBioMedicine. 2020 Oct;60:102991. doi: 10.1016/j.ebiom.2020.102991. Epub 2020 Sep 16.
7
Utility of a Dengue-Derived Monoclonal Antibody to Enhance Zika Infection In Vitro.一种源自登革热的单克隆抗体在体外增强寨卡病毒感染方面的效用
PLoS Curr. 2016 Jul 5;8:ecurrents.outbreaks.4ab8bc87c945eb41cd8a49e127082620. doi: 10.1371/currents.outbreaks.4ab8bc87c945eb41cd8a49e127082620.
8
A Dual-Approach Strategy to Optimize the Safety and Efficacy of Anti-Zika Virus Monoclonal Antibody Therapeutics.一种优化抗寨卡病毒单克隆抗体治疗安全性和疗效的双途径策略。
Viruses. 2023 May 11;15(5):1156. doi: 10.3390/v15051156.
9
Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans.人类在先后感染登革热病毒和 Zika 病毒后,对 Zika 病毒产生了增强的免疫应答。
Viruses. 2018 Sep 7;10(9):480. doi: 10.3390/v10090480.
10
Comparative Analysis of In Vitro Models to Study Antibody-Dependent Enhancement of Zika Virus Infection.比较分析体外模型以研究寨卡病毒感染的抗体依赖性增强作用。
Viruses. 2022 Dec 13;14(12):2776. doi: 10.3390/v14122776.

引用本文的文献

1
Exploring Zika's dynamics: A scoping review journey from epidemic to equations through mathematical modelling.探索寨卡病毒的动态:从疫情到通过数学建模构建方程的范围综述之旅。
Infect Dis Model. 2024 Dec 31;10(2):536-558. doi: 10.1016/j.idm.2024.12.016. eCollection 2025 Jun.
2
Modelling the mechanisms of antibody mixtures in viral infections: the cases of sequential homologous and heterologous dengue infections.模拟病毒感染中抗体混合物的机制:连续同源和异源登革热感染的案例。
J R Soc Interface. 2024 Oct;21(219):20240182. doi: 10.1098/rsif.2024.0182. Epub 2024 Oct 16.
3
A deterministic model for homologous antibody dependant enhancement on influenza infection.

本文引用的文献

1
Control of Acute Arboviral Infection by Natural Killer Cells.自然杀伤细胞对急性虫媒病毒感染的控制作用。
Viruses. 2019 Jan 31;11(2):131. doi: 10.3390/v11020131.
2
A simple mathematical model to describe antibody-dependent enhancement in heterologous secondary infection in dengue.一种描述登革热异源二次感染中抗体依赖增强作用的简单数学模型。
Math Med Biol. 2019 Dec 4;36(4):411-438. doi: 10.1093/imammb/dqy016.
3
A conceptual model for optimizing vaccine coverage to reduce vector-borne infections in the presence of antibody-dependent enhancement.
流感感染中同源抗体依赖性增强作用的确定性模型。
Infect Dis Model. 2024 Jul 18;9(4):1265-1275. doi: 10.1016/j.idm.2024.07.003. eCollection 2024 Dec.
4
Co-infection of dengue and Zika viruses mutually enhances viral replication in the mosquito Aedes aegypti.登革热和寨卡病毒的合并感染在蚊子埃及伊蚊中相互增强病毒复制。
Parasit Vectors. 2023 May 11;16(1):160. doi: 10.1186/s13071-023-05778-1.
5
Data-rich modeling helps answer increasingly complex questions on variant and disease interactions: Comment on "Mathematical models for dengue fever epidemiology: A 10-year systematic review" by Aguiar et al.数据丰富的建模有助于回答关于变异与疾病相互作用的日益复杂的问题:对阿吉亚尔等人所著《登革热流行病学的数学模型:十年系统综述》的评论
Phys Life Rev. 2023 Mar;44:197-200. doi: 10.1016/j.plrev.2023.01.009. Epub 2023 Feb 2.
6
Novel Therapeutic Nutrients Molecules That Protect against Zika Virus Infection with a Special Note on Palmitoleate.新型治疗性营养分子可预防寨卡病毒感染,特别提到棕榈油酸。
Nutrients. 2022 Dec 27;15(1):124. doi: 10.3390/nu15010124.
7
The resurgence risk of COVID-19 in China in the presence of immunity waning and ADE: A mathematical modelling study.中国存在免疫减弱和抗体依赖性增强(ADE)时 COVID-19 复燃风险的数学建模研究。
Vaccine. 2022 Nov 22;40(49):7141-7150. doi: 10.1016/j.vaccine.2022.10.043. Epub 2022 Oct 26.
8
Temporal patterns of functional anti-dengue antibodies in dengue infected individuals with different disease outcome or infection history.不同疾病结局或感染史的登革热感染者体内功能性抗登革热抗体的时间模式。
Sci Rep. 2022 Oct 25;12(1):17863. doi: 10.1038/s41598-022-21722-2.
9
Effects of the Developing and Using a Model to Predict Dengue Risk Villages Based on Subdistrict Administrative Organization in Southern Thailand.基于泰国南部分区行政组织开发和使用预测登革热风险村庄模型的效果。
Int J Environ Res Public Health. 2022 Sep 22;19(19):11989. doi: 10.3390/ijerph191911989.
10
Mathematical models for dengue fever epidemiology: A 10-year systematic review.登革热流行病学的数学模型:一项 10 年系统性回顾。
Phys Life Rev. 2022 Mar;40:65-92. doi: 10.1016/j.plrev.2022.02.001. Epub 2022 Feb 15.
一种在存在抗体依赖性增强作用的情况下优化疫苗接种覆盖率以减少媒介传播感染的概念模型。
Theor Biol Med Model. 2018 Sep 3;15(1):13. doi: 10.1186/s12976-018-0085-x.
4
Mathematical modeling of within-host Zika virus dynamics.宿主内寨卡病毒动力学的数学建模。
Immunol Rev. 2018 Sep;285(1):81-96. doi: 10.1111/imr.12687.
5
Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection. Zika 恢复期猕猴在登革热感染后表现出迟发性回忆性中和抗体反应的诱导。
Emerg Microbes Infect. 2018 Jul 13;7(1):130. doi: 10.1038/s41426-018-0132-z.
6
Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.抗体依赖性增强作用对登革热/寨卡病毒致病性的调节作用及寨卡病毒感染中预防增强作用的策略。
Front Immunol. 2018 Apr 23;9:597. doi: 10.3389/fimmu.2018.00597. eCollection 2018.
7
Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas.亚洲和美洲寨卡病毒和登革热病毒感染后的抗体交叉中和的纵向分析。
J Infect Dis. 2018 Jul 13;218(4):536-545. doi: 10.1093/infdis/jiy164.
8
Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques.先前暴露于 Zika 病毒显著增强恒河猴登革热 2 型病毒血症峰值。
Sci Rep. 2017 Sep 5;7(1):10498. doi: 10.1038/s41598-017-10901-1.
9
Zika plasma viral dynamics in nonhuman primates provides insights into early infection and antiviral strategies.寨卡病毒在非人灵长类动物中的血浆病毒动力学为早期感染和抗病毒策略提供了深入了解。
Proc Natl Acad Sci U S A. 2017 Aug 15;114(33):8847-8852. doi: 10.1073/pnas.1704011114. Epub 2017 Aug 1.
10
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity.既往抗黄病毒免疫增强寨卡病毒致病性
Science. 2017 Apr 14;356(6334):175-180. doi: 10.1126/science.aal4365. Epub 2017 Mar 30.